ATE393217T1 - Verfahren zur reinigung von faktor-ix - Google Patents

Verfahren zur reinigung von faktor-ix

Info

Publication number
ATE393217T1
ATE393217T1 AT96915892T AT96915892T ATE393217T1 AT E393217 T1 ATE393217 T1 AT E393217T1 AT 96915892 T AT96915892 T AT 96915892T AT 96915892 T AT96915892 T AT 96915892T AT E393217 T1 ATE393217 T1 AT E393217T1
Authority
AT
Austria
Prior art keywords
purification
factor
hydroxyapatite
resins
anion exchange
Prior art date
Application number
AT96915892T
Other languages
English (en)
Inventor
W Foster
Robert Costigan
Duane Bonam
Mary Switzer
Rochelle Walsh
Original Assignee
Genetics Inst Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst Llc filed Critical Genetics Inst Llc
Application granted granted Critical
Publication of ATE393217T1 publication Critical patent/ATE393217T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT96915892T 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor-ix ATE393217T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/472,823 US5714583A (en) 1995-06-07 1995-06-07 Factor IX purification methods

Publications (1)

Publication Number Publication Date
ATE393217T1 true ATE393217T1 (de) 2008-05-15

Family

ID=23877079

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96915892T ATE393217T1 (de) 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor-ix
AT05012614T ATE488582T1 (de) 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor ix

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05012614T ATE488582T1 (de) 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor ix

Country Status (11)

Country Link
US (2) US5714583A (de)
EP (2) EP1571208B1 (de)
JP (1) JP3676817B2 (de)
AT (2) ATE393217T1 (de)
AU (1) AU5754396A (de)
CA (1) CA2220501C (de)
DE (2) DE69638291D1 (de)
DK (2) DK0832200T3 (de)
ES (2) ES2306450T3 (de)
PT (2) PT832200E (de)
WO (1) WO1996040883A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
DE69434651T2 (de) 1993-12-07 2007-03-08 Genetics Institute, Inc., Cambridge Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US20030036629A1 (en) * 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
BRPI9910332B8 (pt) 1998-05-06 2021-05-25 Genentech Inc método para purificação de um polipeptídio a partir de uma composição
JP2002526455A (ja) 1998-09-21 2002-08-20 ジェネティックス インスティテュート インク． 治療用たんぱく質に対する免疫応答を下方変調する方法
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
ATE271886T1 (de) 1999-10-15 2004-08-15 Inst Genetics Llc Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
AU2002225681A1 (en) * 2000-11-15 2002-05-27 Globe Immune, Inc. Yeast-dentritic cell vaccines and uses thereof
WO2002099037A2 (en) 2001-06-01 2002-12-12 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
KR100451308B1 (ko) * 2001-12-28 2004-10-06 선바이오(주) 단백질 의약품 정제 방법에서의 바이러스 제거 방법
AU2004230670B2 (en) * 2003-01-09 2010-11-25 Genentech, Inc. Purification of polypeptides
WO2004091487A2 (en) * 2003-04-09 2004-10-28 Wyeth Hemophilia treatment by inhalation of coagulation factors
CA2571292C (en) 2004-06-30 2013-05-21 Nektar Therapeutics Al, Corporation Polymer-factor ix moiety conjugates
PL1969127T5 (pl) 2005-12-21 2018-02-28 Cnj Holdings, Inc Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji
HRP20160990T1 (hr) 2006-03-24 2016-10-07 Biogen Hemophilia Inc. Pc5 kao enzim obrade faktor ix propeptida
DK2125866T3 (da) * 2007-02-28 2013-07-29 Baxter Int Fremgangsmåde til rensning af rekombinant blodkoagulationsfaktor IX, som er beriget med sulfaterede og/eller phosphorylerede molekyler
CA2683423C (en) * 2007-04-26 2020-10-27 Inspiration Biopharmaceuticals, Inc. Recombinant vitamin k dependent proteins with high sialic acid content and methods of preparing same
RU2353386C1 (ru) * 2007-10-11 2009-04-27 Общество с ограниченной ответственностью "БиоГениус" Способ получения концентрата ix фактора свертывания крови человека
CN105315323A (zh) 2007-10-30 2016-02-10 健泰科生物技术公司 通过阳离子交换层析进行的抗体纯化
US20110166332A1 (en) * 2008-09-12 2011-07-07 Ge Healthcare Bio-Sciences Ab Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions
FR2946348B1 (fr) 2009-06-05 2011-08-05 Lab Francais Du Fractionnement Procede de preparation d'une composition de complexe prothrombique a haut degre de purete
ES2475718T3 (es) 2009-07-10 2014-07-11 Csl Limited Método para incrementar el rendimiento de la expresión de proteínas dependientes de vitamina K
EP2494040B1 (de) 2009-10-30 2018-08-29 Aptevo BioTherapeutics LLC Verfahren zur herstellung rekombinanter vitamin-k-abhängiger proteine
WO2011064247A1 (en) 2009-11-24 2011-06-03 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
WO2011121031A1 (en) 2010-03-30 2011-10-06 Octapharma Ag Process for the purification of a growth factor protein
AU2011234521B2 (en) * 2010-03-30 2015-04-23 Octapharma Ag A process for purifying Vitamin K dependent proteins such as coagulation factor IX
JP5883849B2 (ja) * 2010-04-29 2016-03-15 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 陰イオン交換樹脂を用いる二価カチオン結合タンパク質の精製方法
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
CA2847818A1 (en) * 2011-09-06 2013-03-14 Medimmune, Llc Methods for processing coagulation factors
LT2748179T (lt) * 2011-10-14 2022-04-11 Takeda Pharmaceutical Company Limited Baltymų gryninimas anijonų mainų chromatografija
EP2748180B1 (de) * 2011-10-14 2018-08-15 Baxalta GmbH Proteinaufreinigung mithilfe der anionenaustauschchromatographie
TR201808584T4 (tr) 2013-03-15 2018-07-23 Baxalta GmbH Anyon değişimi kromotografisi aracılığıyla k vitaminine bağlı proteinler için saflaştırma yöntemi.
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
CN114134109B (zh) * 2021-12-10 2023-01-24 广州远想生物科技股份有限公司 Egf间充质干细胞外泌体的纯化方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4447416A (en) * 1982-04-28 1984-05-08 American National Red Cross Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
DE3486350T2 (de) * 1983-10-28 1995-03-16 New England Medical Center Inc VERFAHREN ZUR ISOLIERUNG EINES PROTEINS AUS EINER DIESES PROTEIN ENTHALTENDEN MISCHUNG UNTER VERWENDUNG EINES KONFORMATIONSSPEZIFISCHEN ANTIKöRPERS.
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
US4831118A (en) * 1987-08-07 1989-05-16 Scripps Clinic And Research Foundation Flouroplastic immunoaffinity columns for purification of blood proteins
EP0317376B2 (de) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat
WO1989005652A1 (en) * 1987-12-21 1989-06-29 American National Red Cross Pure factor ix product
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
US5118614A (en) * 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
DE3826792C1 (de) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
DE3914869C1 (de) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods

Also Published As

Publication number Publication date
DK0832200T3 (da) 2008-07-21
CA2220501A1 (en) 1996-12-19
JPH11506603A (ja) 1999-06-15
DE69637509T2 (de) 2009-05-28
US6627737B1 (en) 2003-09-30
AU5754396A (en) 1996-12-30
DE69638291D1 (de) 2010-12-30
ES2353798T3 (es) 2011-03-07
EP0832200B1 (de) 2008-04-23
PT1571208E (pt) 2011-01-04
DE69637509D1 (de) 2008-06-05
EP0832200A1 (de) 1998-04-01
EP1571208B1 (de) 2010-11-17
US5714583A (en) 1998-02-03
ES2306450T3 (es) 2008-11-01
DK1571208T3 (da) 2011-01-24
EP1571208A1 (de) 2005-09-07
JP3676817B2 (ja) 2005-07-27
WO1996040883A1 (en) 1996-12-19
ATE488582T1 (de) 2010-12-15
PT832200E (pt) 2008-07-17
CA2220501C (en) 2014-01-07

Similar Documents

Publication Publication Date Title
ATE488582T1 (de) Verfahren zur reinigung von faktor ix
DE3585147D1 (de) Verfahren zur reinigung von proteinen.
SE9404250L (sv) Affinitetsseparationsmetod
DE69715234D1 (de) Verfahren zur reinigung von 1,1-difluorethan
KR890700666A (ko) 혈관 항응고 단백질, 이를 암호화하는 dna, 이의 제조방법 및 용도
DE3680738D1 (de) Verfahren zur reinigung von kieselsaeure.
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE3587298D1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
DE69504433D1 (de) Verfahren zur Herstellung von korrosionsbeständigen, porösen metallischen Bauteilen
DE68901643D1 (de) Verfahren zur beschichtung von kohlenstoffkoerpern.
ATA18695A (de) Verfahren zur reinigung von melamin
DE69003423D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan.
DE3873094D1 (de) Verfahren zur aufbereitung von gas.
DE69522807D1 (de) Verfahren zur herstellung von feinkörnigen, modifizierten stärken
ATE118498T1 (de) Verfahren zur reinigung von n- phosphonmethylglyzin.
DE3677723D1 (de) Verfahren zur spanlosen umformung von metallen.
DE69719247D1 (de) Ionenaustauscher, Verfahren zu dessen Herstellung und Verwendung desselben zur Entfernung von mehrwertigen Anionen
ATE240969T1 (de) VERFAHREN ZUR REINIGUNG VON ßBASICß FIBROBLASTEN WACHSTUMSFAKTOR
ATE173272T1 (de) Verfahren zur reaktivierung von gereinigten membranproteinen
DE69618481D1 (de) Verfahren zur herstellung von halogenkohlenwasserstoffen
DE58900532D1 (de) Verfahren zur herstellung von bifunktionellen anionenaustauschharzen, neue bifunktionelle anionenaustauschharze und ihre verwendung.
ATE435228T1 (de) Verfahren zur herstellung von 2-methylspiro(1,3- oxathiolan-5,3')chinuclidin
DE69426837D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluoro-2,3-dichloropropan
DE69811677D1 (de) Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen.
DE3863411D1 (de) Verfahren zur reinigung von wasserstoff.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0832200

Country of ref document: EP